To maintain heart health, Dr. Obuobi recommends 30 minutes of moderate exercise weekly. Monitoring heart rate is essential, and walking is a great option.
To an onlooker, the biggest difference between these two wearables is, well, where you wear them. The Oura ring, obviously, is a ring, while Whoop is typically worn on the wrist — though you can put ...
At Valour Ring 1 offers 24x7 heart rate, sleep tracking, 40+ sports modes and up to 15 days battery, priced at Rs 11999, ...
Technology-driven fitness systems turn physical movement into gameplay, nudging even the most passive screen users into ...
Morning Overview on MSN
Tennis could add nearly 10 years to your life, study says
Tennis is emerging as one of the most powerful longevity tools in modern medicine, with large population studies suggesting it can add close to a decade to the average life span of regular players.
Cycling Weekly on MSN
'When the call of cake proved too powerful, the graph reacted predictably': my life with a continuous glucose monitor
However, when things went a bit sideways and the call of the cake tin proved more powerful than my own will, the line on the ...
AZ Animals US on MSN
Why You Should Let Your Dog Stop and Sniff on Your Walks
Dogs have extraordinary noses and brains built to interpret scent. Allowing them the time to sniff regularly has many ...
FITBOOK magazine on MSN
How to Train the Nervous System to Age More Slowly
I am an expert in neurocentric training and work with my clients on life-extending daily routines. In my book “Your Longevity ...
Cycling and running both improve fitness. Learn how they compare to decide which fits your goals and lifestyle best.
Daily cardio leads to a number of health benefits, especially for your heart, lungs, and overall fitness level. Just be careful not to overdo it, experts caution.
Rising prevalence of valvular heart diseases, expanding elderly population, and growing preference for minimally invasive cardiac procedures are driving the transcatheter heart valve replacement ...
BioCardia®, Inc. [NASDAQ: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, announces it has completed a third preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results